Cancer Diagnostics News, Articles | Today's Clinical Lab

Illustration of a vast array of colorful DNA banding from ddPCR to visually represent the data produced by the new groundbreaking tool, Ultra-Rapid droplet digital PCR (UR-ddPCR).

New ‘Ultra-Rapid’ ddPCR Test Could Revolutionize Brain Cancer Surgery

Today's Clinical Lab

A new, ultra-fast genetic test developed by NYU Langone Health may enable surgeons to identify cancer cells in real-time during brain surgery, improving tumor removal accuracy

Amplified Sciences—led by CEO Diana Caldwell (right) and chief scientific officer V. Jo Davisson—has received regulatory clearance under the federal Clinical Laboratory Improvement Amendments program to test PanCystPro, which risk stratifies patients with pancreatic cystic lesions, a precursor for pancreatic cancer. The company was featured in the Indiana Economic Development Corp.’s 2024 edition of Entrepreneurship Indiana.

Amplified Sciences Earns CLIA Certification for Its First Test to Assess Pancreatic Cancer Risk

Purdue University

Company to commercialize PanCystPro, including establishing an early access program and completing a clinical utility trial in 2025

Abstract illustration showing colorful bars representing data from breast cancer testing organized into multiple rows against a dark background.

New Data to Be Presented at SABCS 2024 Investigates the Potential Role of the Breast Cancer Index® Test in Identifying Patients with Minimal Risk of Distant Recurrence

Hologic

Study assesses prognostic value of BCI testing and its potential in supporting de-escalation of primary adjuvant endocrine therapy

Illustration of colorectal tumor cancer cells on a representative drawing of major organs inside the human body against a black background.

In Five Cancer Types, Prevention and Screening Have Been Major Contributors to Saving Lives

National Institutes of Health, National Cancer Institute

NIH modeling study looked at the individual and combined impacts of cancer prevention, screening, and treatment

Photo of a clinical laboratory scientist wearing a white lab coat standing with their arms crossed inside of a medical laboratory where testing is conducted.

Study Seeks Rapid, Paper-Based Test to Detect Cancer Cells in Cerebrospinal Fluid

University of California - Los Angeles, UCLA Health

UCLA researchers look to create point-of-care test that can confirm diagnosis at the bedside

Illustration of the cover of the 2024 September Cancer & Pathology Digital Edition of Today's Clinical Lab.

'Navigating Change at the Bench'

Miriam Bergeret, MSc

The Today's Clinical Lab 2024 Cancer & Pathology print issue features innovations in early cancer detection and digital pathology

Photo of a clinical technician wearing PPE examining a colonoscopy on a monitor in a clinic.

New Biomarker Candidates for Colon Cancer

Michael Schubert, PhD

New biomarker candidates may help determine which colon cancer patients are most likely to benefit from chemotherapy

(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of Computational Biology, Vidya Balagopal, St. Jude Department of Pathology and Pandurang Kolekar, PhD, St. Jude Department of Computational Biology.

New Gene Panel for Pediatric Cancers Increases Access to High-Quality Testing

St. Jude Children’s Research Hospital

Researchers at St. Jude Children’s Research Hospital have created a cost-effective, easy-to-use test to categorize a child’s cancer and guide better treatment